Arch Venture Management’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42.4M Hold
3,728,738
14.19% 4
2025
Q1
$37.5M Hold
3,728,738
18.21% 3
2024
Q4
$66.1M Hold
3,728,738
28.73% 2
2024
Q3
$76.4M Hold
3,728,738
29.31% 2
2024
Q2
$86.7M Buy
+3,728,738
New +$86.7M 32.6% 2